← Leaderboards
Jay Evans
Corixa Corporation
$13,735,700
Attributed
$13,735,700
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.1M · FY2014–19$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$13,735,700 · 1
By mechanism
N01$13,735,700 · 1
Top collaborators
No co-investigators on record.
Most similar at Corixa Corporation
Same institution · by research overlap
- David Johnson$22,189,736
- Witold Cieplak$2,691,277
Others in their field
Top investigators on “Signal Pathway”
- David Heimbrook · Leidos Biomedical Research, Inc.$191,912,844
- Asrar B. Malik · University Of Illinois At Chicago$75,811,832
- Robert H Tukey · University Of California San Diego$50,504,865
- Meenhard Herlyn · University Of Pennsylvania$50,308,097
- Ian A Wilson · Scripps Research Institute, The$50,300,809
- Richard D Smith · Battelle Pacific Northwest Laboratories$46,192,560
Research focus
Signal PathwayAdjuvantAdjuvanticityAgonistAnimal ModelCellsContractorC Type Lectin ReceptorsReceptorSignal TransductionSmall Molecule LibrariesStructure-Activity RelationshipTechnologyTraffickingVaccine AdjuvantVaccinesValidationEmerging Communicable DiseasesEvaluationHigh Throughput ScreeningHuman DiseaseImmunologic ReceptorsInsightInterleukin-17
Grant awards (4)
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis$847,164
N01 · FY2019 · AI · contact PI
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis$5,009,797
N01 · FY2018 · AI · contact PI
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis$2,796,602
N01 · FY2017 · AI · contact PI
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis$5,082,137
N01 · FY2014 · AI · contact PI